The National Institute on Drug Abuse (NIDA) has issued a Request for Information (RFI) on the impact of telehealth initiation of controlled substances. As part of the Administration’s response to the COVID-19 pandemic, the Drug Enforcement Agency (DEA) waived the requirement that a healthcare provider must see a patient in-person at least once to prescribe controlled substances via telehealth. The… (Marceno, July 14, 2023) #Mental and Behavioral Health, #National Institutes of Health, #Opioids